Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules. [PDF]
JAMA Surg, 2018 Clinicians rely heavily on fluorodeoxyglucose F18-labeled positron emission tomography (FDG-PET) imaging to evaluate lung nodules suspicious for cancer. We evaluated the performance of FDG-PET for the diagnosis of malignancy in differing populations with varying cancer prevalence.To determine the performance of FDG-PET/computed tomography (CT) in ...
Maiga AW +12 more
europepmc +5 more sources
Fluorodeoxyglucose F18 PET in progressive emotional dysprosody. [PDF]
Neurology, 2012 While the left hemisphere is important for semantic and grammatical language, the right hemisphere appears to be important for prosody.
Graff-Radford J +3 more
europepmc +7 more sources
Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose [PDF]
Frontiers in Medicine, 2022 Lung cancer has been the leading cause of cancer-related mortality in China in recent decades. Positron emission tomography-computer tomography (PET/CT) has been established in the diagnosis of lung cancer. 18F-FDG is the most widely used PET tracer in foci diagnosis, tumor staging, treatment planning, and prognosis assessment by monitoring abnormally ...
Jing Zhu +8 more
semanticscholar +5 more sources
Indian Journal of Nuclear Medicine, 2021 A variety of fungal pulmonary infections can produce radiologic findings that mimic malignancy. Distinguishing these infectious lesions from malignancy remains challenging for physicians. We describe one such case where fungal lung nodule mimicked metastasis on fluorodeoxyglucose positron emission tomography/computed ...
Atul Gosavi +6 more
semanticscholar +6 more sources
F18‑fluorodeoxyglucose positron emission tomography/computed tomography for bone hemangiopericytoma
Molecular and Clinical Oncology, 2017 Bone hemangiopericytoma (HPC) is extremely rare, and its clinical manifestations and radiographic features are nonspecific. There are few case reports about application of F18-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in HPC.
Yiyan Liu
semanticscholar +5 more sources
Discordant Findings of Skeletal Metastasis Between Tc99m MDP Bone Scans and F18 FDG PET/CT Imaging for Advanced Breast and Lung Cancers—Two Case Reports and Literature Review [PDF]
Kaohsiung Journal of Medical Sciences, 2007 Traditionally, Tc99m methyl diphosphate (MDP) bone scintigraphy provides high-sensitivity detection of skeletal metastasis from breast and lung cancers in regular follow-up.
Yu-Wen Chen +5 more
doaj +3 more sources
F18 fluorodeoxyglucose uptake in progressive transformation of germinal centres [PDF]
Biomedical Imaging and Intervention Journal, 2008 FDG-PET/CT is a widely established imaging modality for staging, restaging and monitoring therapy response in lymphoma patients. Progressive transformation of germinal centres (PTGC) is a benign condition presenting characteristically as asymptomatic lymphadenopathy.
Bhavya Rehani +4 more
openalex +5 more sources
Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis [PDF]
Journal of Nuclear Cardiology, 2014 Sarcoidosis is a disease of unknown etiology which is characterized by the formation of non-caseating granulomas in multiple organs. Cardiac involvement in sarcoidosis, which occurs in at least one in four patients, is associated with a worse prognosis and significant morbidity from conduction abnormalities, arrhythmias, and congestive heart failure ...
Alfonso H. Waller, Ron Blankstein
openalex +4 more sources
Quantitative F18‐fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign [PDF]
Cancer, 2009 AbstractBACKGROUND:Correct pretreatment classification is critical for optimizing diagnosis and treatment of patients with peripheral nerve sheath tumors (PNSTs). The aim of this study was to evaluate whether F18‐fluorodeoxyglucose positron emission tomography (FDG PET) can differentiate malignant (MPNST) from benign PNSTs.METHODS:Thirty‐four adult ...
Matthias Benz +8 more
openalex +5 more sources
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma [PDF]
Blood, 2009 AbstractF18-fluorodeoxyglucose positron emission tomography (FDG-PET) is a powerful tool to investigate the role of tumor metabolic activity and its suppression by therapy for cancer survival. As part of Total Therapy 3 for newly diagnosed multiple myeloma, metastatic bone survey, magnetic resonance imaging, and FDG-PET scanning were evaluated in 239 ...
Twyla B. Bartel +11 more
openalex +4 more sources